Invention Grant
- Patent Title: Interleukin-4 receptor-binding fusion proteins and uses thereof
-
Application No.: US16125566Application Date: 2018-09-07
-
Publication No.: US11352402B2Publication Date: 2022-06-07
- Inventor: Fahar Merchant , Raj K. Puri , Bharatkumar H. Joshi
- Applicant: Medicenna Therapeutics Inc.
- Applicant Address: CA Toronto
- Assignee: Medicenna Therapeutics Inc.
- Current Assignee: Medicenna Therapeutics Inc.
- Current Assignee Address: CA Toronto
- Agency: Morgan, Lewis & Bockius, LLP
- Agent Sara E. Sims; Christina A. MacDougall
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K38/20 ; C07K14/47 ; C07K14/54 ; C07K19/00 ; C12N15/63 ; C12N5/071 ; A61K38/19 ; C12N5/0783 ; A61K38/00
Abstract:
The present invention relates to interleukin-4 receptor-binding fusion proteins. More specifically, the invention provides, in part, fusion proteins that include an interleukin-4 or interleukin-13 protein moiety joined to an anti-apoptotic Bcl-2 family member protein moiety.
Public/Granted literature
- US20190100568A1 INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF Public/Granted day:2019-04-04
Information query
IPC分类:
